Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

April 23, 2018

Study Completion Date

April 23, 2018

Conditions
Knee Osteoarthritis
Interventions
COMBINATION_PRODUCT

Cingal

Hyaluronic Acid with Triamcinolone Hexacetonide

DEVICE

Monovisc

Hyaluronic acid

DRUG

Triamcinolone Hexacetonide

Triamcinolone Hexacetonide

Trial Locations (19)

1051

Health Center of Downtown-Lipotvaros, Orthopedic Outpatient Clinic (Belvárosi-Lipótvárosi Egészségügyi Szolgálat Ortopeadia), Budapest

1134

Magyar Honvedseg, Budapest

2890

Kastelypark Klinka, Tata

6000

Jutrix Medical Llc, Kecskemét

6100

Medidea Bt., Kiskunfélegyháza

29-41

Uzsoki Utcai Kórház, Budapest

Unknown

Baleseti Központ, Budapest

DE KK Ortopediai Klinika, Debrecen

Zdrowie Osteo-Medic, Bialystok

Szpital Świętego Łukasza S.A., Bielsko-Biala

NZOZ Medi SPATZ, Gliwice

ARTIMED Niepubliczny Zakład Opieki Zdrowotnej, Kielce

Centrum Medyczne 4M Plus, Krakow

Medical University of Lodz, Lodz

Lubelskie Centrum Diagnostyczne, Świdnik

NOVAMED Jackowiak Krajewski Spółka Jawna, Torun

Centrum Medyczne Amed Warszawa Targówek, Warsaw

ETG Network, Warsaw, Warsaw

ETG Network, Warsaw

Sponsors
All Listed Sponsors
lead

Anika Therapeutics, Inc.

INDUSTRY